Stemline amends IPO

Stemline Therapeutics Inc., New York, N.Y. Business: Cancer Date announced: 10/22/12 Type: IPO To be raised: Up to $25.1 million Shares: 1.8 million Price: $10-$12 Underwriter: Aegis Capital Overallot...